In this regard, studies have shown that, even without a significant increase in BAX, the reduction in BCL-2 expression can be sufficient to destabilize the mitochondrial membrane potential, especially in cancer cells dependent on BCL-2 for survival. This evidence concerns the gene BCL2 and cancer.